25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Relief Therapeutics Holding SA
Buy, Hold or Sell?

Let's analyze Relief Therapeutics Holding SA together

I guess you are interested in Relief Therapeutics Holding SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Relief Therapeutics Holding SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Relief Therapeutics Holding SA

I send you an email if I find something interesting about Relief Therapeutics Holding SA.

1. Quick Overview

1.1. Quick analysis of Relief Therapeutics Holding SA (30 sec.)










1.2. What can you expect buying and holding a share of Relief Therapeutics Holding SA? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.70
Expected worth in 1 year
$23.35
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$18.65
Return On Investment
252.8%

For what price can you sell your share?

Current Price per Share
$7.38
Expected price per share
$3.58 - $9
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Relief Therapeutics Holding SA (5 min.)




Live pricePrice per Share (EOD)
$7.38
Intrinsic Value Per Share
$-23.98 - $-17.39
Total Value Per Share
$-19.28 - $-12.69

2.2. Growth of Relief Therapeutics Holding SA (5 min.)




Is Relief Therapeutics Holding SA growing?

Current yearPrevious yearGrowGrow %
How rich?$58.9m$164.1m-$105.1m-178.4%

How much money is Relief Therapeutics Holding SA making?

Current yearPrevious yearGrowGrow %
Making money-$110.8m-$57.3m-$53.4m-48.3%
Net Profit Margin-1,627.4%-835.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Relief Therapeutics Holding SA (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#433 / 959

Most Revenue
#322 / 959

Most Profit
#925 / 959

Most Efficient
#763 / 959
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Relief Therapeutics Holding SA?

Welcome investor! Relief Therapeutics Holding SA's management wants to use your money to grow the business. In return you get a share of Relief Therapeutics Holding SA.

First you should know what it really means to hold a share of Relief Therapeutics Holding SA. And how you can make/lose money.

Speculation

The Price per Share of Relief Therapeutics Holding SA is $7.38. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Relief Therapeutics Holding SA.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Relief Therapeutics Holding SA, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.70. Based on the TTM, the Book Value Change Per Share is $4.66 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Relief Therapeutics Holding SA.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-8.84-119.7%-8.84-119.7%-0.01-0.2%-1.77-24.0%-1.30-17.6%
Usd Book Value Change Per Share4.6663.2%4.6663.2%-0.01-0.2%0.9412.7%0.598.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share4.6663.2%4.6663.2%-0.01-0.2%0.9412.7%0.598.0%
Usd Price Per Share2.22-2.22-0.03-0.52-0.33-
Price to Earnings Ratio-0.25--0.25--2.25--24.65--15.40-
Price-to-Total Gains Ratio0.48-0.48--2.33-5.09-5.09-
Price to Book Ratio0.47-0.47-0.79-3.17-1.98-
Price-to-Total Gains Ratio0.48-0.48--2.33-5.09-5.09-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.38
Number of shares135
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share4.660.94
Usd Total Gains Per Share4.660.94
Gains per Quarter (135 shares)629.57126.61
Gains per Year (135 shares)2,518.30506.44
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10251825080506496
2050375026010131002
3075557544015191508
401007310062020262014
501259112580025322520
601511015098030393026
701762817616035453532
802014620134040524038
902266522652045584544
1002518325170050645050

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.08.00.00.0%0.08.00.00.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%4.04.00.050.0%4.04.00.050.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%4.04.00.050.0%4.04.00.050.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Relief Therapeutics Holding SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--4.6644.6640%-0.013+100%0.938+397%0.588+694%
Book Value Per Share--4.7014.7010%0.037+12517%0.964+388%0.855+450%
Current Ratio--2.6492.6490%2.107+26%2.927-9%1.909+39%
Debt To Asset Ratio--0.3160.3160%0.230+38%0.249+27%0.283+12%
Debt To Equity Ratio--0.4630.4630%0.298+55%0.340+36%0.408+13%
Dividend Per Share----0%-0%-0%-0%
Eps---8.837-8.8370%-0.013-100%-1.773-80%-1.298-85%
Free Cash Flow Per Share---1.625-1.6250%-0.006-100%-0.330-80%-0.236-85%
Free Cash Flow To Equity Per Share---1.261-1.2610%-0.005-100%-0.249-80%-0.178-86%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---17.391--------
Intrinsic Value_10Y_min---23.983--------
Intrinsic Value_1Y_max---0.636--------
Intrinsic Value_1Y_min---1.026--------
Intrinsic Value_3Y_max---2.755--------
Intrinsic Value_3Y_min---4.295--------
Intrinsic Value_5Y_max---5.890--------
Intrinsic Value_5Y_min---8.865--------
Market Cap92548152.000+70%27839774.58027839774.5800%129081887.950-78%286074226.917-90%178796391.823-84%
Net Profit Margin---16.274-16.2740%-8.352-49%-7.015-57%-144.764+790%
Operating Margin----0%-5.7900%-3.2200%-142.1310%
Operating Ratio--4.5664.5660%9.292-51%6.286-27%22.169-79%
Pb Ratio1.570+70%0.4720.4720%0.786-40%3.172-85%1.983-76%
Pe Ratio-0.835-232%-0.251-0.2510%-2.252+796%-24.646+9711%-15.404+6032%
Price Per Share7.380+70%2.2202.2200%0.029+7477%0.525+323%0.328+577%
Price To Free Cash Flow Ratio-4.541-232%-1.366-1.3660%-4.640+240%-11.928+773%-7.455+446%
Price To Total Gains Ratio1.582+70%0.4760.4760%-2.334+590%5.093-91%5.093-91%
Quick Ratio--0.1690.1690%0.123+37%0.086+98%0.064+164%
Return On Assets---1.285-1.2850%-0.269-79%-0.434-66%-0.351-73%
Return On Equity---1.880-1.8800%-0.349-81%-0.612-67%-0.497-74%
Total Gains Per Share--4.6644.6640%-0.013+100%0.938+397%0.588+694%
Usd Book Value--58949743.60058949743.6000%164132167.900-64%103956881.840-43%74068115.750-20%
Usd Book Value Change Per Share--4.6644.6640%-0.013+100%0.938+397%0.588+694%
Usd Book Value Per Share--4.7014.7010%0.037+12517%0.964+388%0.855+450%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---8.837-8.8370%-0.013-100%-1.773-80%-1.298-85%
Usd Free Cash Flow---20382064.600-20382064.6000%-27819068.900+36%-25082648.620+23%-15929343.100-22%
Usd Free Cash Flow Per Share---1.625-1.6250%-0.006-100%-0.330-80%-0.236-85%
Usd Free Cash Flow To Equity Per Share---1.261-1.2610%-0.005-100%-0.249-80%-0.178-86%
Usd Market Cap92548152.000+70%27839774.58027839774.5800%129081887.950-78%286074226.917-90%178796391.823-84%
Usd Price Per Share7.380+70%2.2202.2200%0.029+7477%0.525+323%0.328+577%
Usd Profit---110816894.700-110816894.7000%-57326673.000-48%-44914133.360-59%-30915234.088-72%
Usd Revenue--6809447.1006809447.1000%6863624.700-1%3484296.900+95%2259516.313+201%
Usd Total Gains Per Share--4.6644.6640%-0.013+100%0.938+397%0.588+694%
 EOD+6 -2MRQTTM+0 -0YOY+13 -195Y+12 -2010Y+13 -19

3.3 Fundamental Score

Let's check the fundamental score of Relief Therapeutics Holding SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.835
Price to Book Ratio (EOD)Between0-11.570
Net Profit Margin (MRQ)Greater than0-16.274
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.169
Current Ratio (MRQ)Greater than12.649
Debt to Asset Ratio (MRQ)Less than10.316
Debt to Equity Ratio (MRQ)Less than10.463
Return on Equity (MRQ)Greater than0.15-1.880
Return on Assets (MRQ)Greater than0.05-1.285
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Relief Therapeutics Holding SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.630
Ma 20Greater thanMa 506.733
Ma 50Greater thanMa 1004.670
Ma 100Greater thanMa 2002.979
OpenGreater thanClose7.570
Total5/5 (100.0%)

4. In-depth Analysis

4.1 About Relief Therapeutics Holding SA

Relief Therapeutics Holding SA, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of rare metabolic, dermatological, and pulmonary diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting; OLPRUVA, a sodium phenylbutyrate for the treatment of urea cycle disorders, and maple syrup urine disease; and PKU GOLIKE for for the dietary management of phenylketonuria. It also develops TYR GOLIKE, that has completed Phase III clinical trial to treat Tyrosinemia; and RLF-100, a synthetic form of vasoactive intestinal peptide (VIP), that is in Phase II clinical trial for the treatment of acute respiratory distress syndrome (ARDS) associated with COVID-19 related ARDS and in preclinical trial to treat pulmonary sarcoidosis, checkpoint inhibitor-induced pneumonitis, and chronic berylliosis. In addition, the company also develops HCU GOLIKE, which is in Phase I clinical trial for the treatment of Homocystinuria; and RLF-TD011, a hypochlorous acid topical sprayable solution, that is in Phase I clinical trial to treat wound colonization, reduce local inflammation, alleviate symptoms, and hasten wound healing in epidermolysis bullosa. Further, it is developing RLF-OD32, which is in Phase I clinical trial for the treatment of patients with phenylketonuria; and. Relief Therapeutics Holding SA was founded in 2013 and is based in Geneva, Switzerland.

Fundamental data was last updated by Penke on 2024-11-06 18:26:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Relief Therapeutics Holding SA earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Relief Therapeutics Holding SA to the Biotechnology industry mean.
  • A Net Profit Margin of -1,627.4% means that $-16.27 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Relief Therapeutics Holding SA:

  • The MRQ is -1,627.4%. The company is making a huge loss. -2
  • The TTM is -1,627.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,627.4%TTM-1,627.4%0.0%
TTM-1,627.4%YOY-835.2%-792.2%
TTM-1,627.4%5Y-701.5%-925.9%
5Y-701.5%10Y-14,476.4%+13,774.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,627.4%-133.6%-1,493.8%
TTM-1,627.4%-204.9%-1,422.5%
YOY-835.2%-207.4%-627.8%
5Y-701.5%-353.5%-348.0%
10Y-14,476.4%-466.1%-14,010.3%
4.3.1.2. Return on Assets

Shows how efficient Relief Therapeutics Holding SA is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Relief Therapeutics Holding SA to the Biotechnology industry mean.
  • -128.5% Return on Assets means that Relief Therapeutics Holding SA generated $-1.29 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Relief Therapeutics Holding SA:

  • The MRQ is -128.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -128.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-128.5%TTM-128.5%0.0%
TTM-128.5%YOY-26.9%-101.6%
TTM-128.5%5Y-43.4%-85.2%
5Y-43.4%10Y-35.1%-8.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-128.5%-10.8%-117.7%
TTM-128.5%-11.8%-116.7%
YOY-26.9%-11.0%-15.9%
5Y-43.4%-12.6%-30.8%
10Y-35.1%-14.4%-20.7%
4.3.1.3. Return on Equity

Shows how efficient Relief Therapeutics Holding SA is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Relief Therapeutics Holding SA to the Biotechnology industry mean.
  • -188.0% Return on Equity means Relief Therapeutics Holding SA generated $-1.88 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Relief Therapeutics Holding SA:

  • The MRQ is -188.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -188.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-188.0%TTM-188.0%0.0%
TTM-188.0%YOY-34.9%-153.1%
TTM-188.0%5Y-61.2%-126.8%
5Y-61.2%10Y-49.7%-11.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-188.0%-13.5%-174.5%
TTM-188.0%-15.9%-172.1%
YOY-34.9%-13.5%-21.4%
5Y-61.2%-18.6%-42.6%
10Y-49.7%-19.0%-30.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Relief Therapeutics Holding SA.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Relief Therapeutics Holding SA is operating .

  • Measures how much profit Relief Therapeutics Holding SA makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Relief Therapeutics Holding SA to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Relief Therapeutics Holding SA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-579.0%+579.0%
TTM-5Y-322.0%+322.0%
5Y-322.0%10Y-14,213.1%+13,891.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--277.1%+277.1%
TTM--312.9%+312.9%
YOY-579.0%-222.0%-357.0%
5Y-322.0%-385.5%+63.5%
10Y-14,213.1%-495.6%-13,717.5%
4.3.2.2. Operating Ratio

Measures how efficient Relief Therapeutics Holding SA is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 4.57 means that the operating costs are $4.57 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Relief Therapeutics Holding SA:

  • The MRQ is 4.566. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.566. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.566TTM4.5660.000
TTM4.566YOY9.292-4.726
TTM4.5665Y6.286-1.720
5Y6.28610Y22.169-15.883
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5662.842+1.724
TTM4.5663.198+1.368
YOY9.2923.301+5.991
5Y6.2864.800+1.486
10Y22.1696.530+15.639
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Relief Therapeutics Holding SA.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Relief Therapeutics Holding SA is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.65 means the company has $2.65 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Relief Therapeutics Holding SA:

  • The MRQ is 2.649. The company is able to pay all its short-term debts. +1
  • The TTM is 2.649. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.649TTM2.6490.000
TTM2.649YOY2.107+0.542
TTM2.6495Y2.927-0.278
5Y2.92710Y1.909+1.018
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6493.788-1.139
TTM2.6493.923-1.274
YOY2.1074.711-2.604
5Y2.9275.959-3.032
10Y1.9096.278-4.369
4.4.3.2. Quick Ratio

Measures if Relief Therapeutics Holding SA is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Relief Therapeutics Holding SA to the Biotechnology industry mean.
  • A Quick Ratio of 0.17 means the company can pay off $0.17 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Relief Therapeutics Holding SA:

  • The MRQ is 0.169. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.169. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.169TTM0.1690.000
TTM0.169YOY0.123+0.046
TTM0.1695Y0.086+0.084
5Y0.08610Y0.064+0.022
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1693.381-3.212
TTM0.1693.526-3.357
YOY0.1234.682-4.559
5Y0.0865.922-5.836
10Y0.0646.458-6.394
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Relief Therapeutics Holding SA.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Relief Therapeutics Holding SA assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Relief Therapeutics Holding SA to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.32 means that Relief Therapeutics Holding SA assets are financed with 31.6% credit (debt) and the remaining percentage (100% - 31.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Relief Therapeutics Holding SA:

  • The MRQ is 0.316. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.316. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.316TTM0.3160.000
TTM0.316YOY0.230+0.087
TTM0.3165Y0.249+0.067
5Y0.24910Y0.283-0.034
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3160.338-0.022
TTM0.3160.347-0.031
YOY0.2300.310-0.080
5Y0.2490.365-0.116
10Y0.2830.381-0.098
4.5.4.2. Debt to Equity Ratio

Measures if Relief Therapeutics Holding SA is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Relief Therapeutics Holding SA to the Biotechnology industry mean.
  • A Debt to Equity ratio of 46.3% means that company has $0.46 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Relief Therapeutics Holding SA:

  • The MRQ is 0.463. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.463. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.463TTM0.4630.000
TTM0.463YOY0.298+0.164
TTM0.4635Y0.340+0.123
5Y0.34010Y0.408-0.068
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4630.387+0.076
TTM0.4630.437+0.026
YOY0.2980.375-0.077
5Y0.3400.450-0.110
10Y0.4080.489-0.081
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Relief Therapeutics Holding SA generates.

  • Above 15 is considered overpriced but always compare Relief Therapeutics Holding SA to the Biotechnology industry mean.
  • A PE ratio of -0.25 means the investor is paying $-0.25 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Relief Therapeutics Holding SA:

  • The EOD is -0.835. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.251. Based on the earnings, the company is expensive. -2
  • The TTM is -0.251. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.835MRQ-0.251-0.584
MRQ-0.251TTM-0.2510.000
TTM-0.251YOY-2.252+2.000
TTM-0.2515Y-24.646+24.395
5Y-24.64610Y-15.404-9.242
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.835-2.384+1.549
MRQ-0.251-2.428+2.177
TTM-0.251-2.991+2.740
YOY-2.252-3.440+1.188
5Y-24.646-6.006-18.640
10Y-15.404-6.278-9.126
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Relief Therapeutics Holding SA:

  • The EOD is -4.541. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.366. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.366. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.541MRQ-1.366-3.175
MRQ-1.366TTM-1.3660.000
TTM-1.366YOY-4.640+3.274
TTM-1.3665Y-11.928+10.563
5Y-11.92810Y-7.455-4.473
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.541-3.160-1.381
MRQ-1.366-3.222+1.856
TTM-1.366-3.516+2.150
YOY-4.640-4.582-0.058
5Y-11.928-8.076-3.852
10Y-7.455-8.950+1.495
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Relief Therapeutics Holding SA is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.47 means the investor is paying $0.47 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Relief Therapeutics Holding SA:

  • The EOD is 1.570. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.472. Based on the equity, the company is cheap. +2
  • The TTM is 0.472. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.570MRQ0.472+1.098
MRQ0.472TTM0.4720.000
TTM0.472YOY0.786-0.314
TTM0.4725Y3.172-2.700
5Y3.17210Y1.983+1.190
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.5701.964-0.394
MRQ0.4721.983-1.511
TTM0.4722.197-1.725
YOY0.7862.404-1.618
5Y3.1723.596-0.424
10Y1.9834.223-2.240
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Gross Profit  -77-15,355-15,432-3,139-18,57110,035-8,53513,3854,850



6.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CHF. All numbers in thousands.

Summary
Total Assets76,390
Total Liabilities24,162
Total Stockholder Equity52,228
 As reported
Total Liabilities 24,162
Total Stockholder Equity+ 52,228
Total Assets = 76,390

Assets

Total Assets76,390
Total Current Assets18,304
Long-term Assets58,086
Total Current Assets
Cash And Cash Equivalents 14,556
Net Receivables 1,171
Inventory 557
Total Current Assets  (as reported)18,304
Total Current Assets  (calculated)16,284
+/- 2,020
Long-term Assets
Property Plant Equipment 2,967
Goodwill 546
Intangible Assets 53,868
Long-term Assets Other 116
Long-term Assets  (as reported)58,086
Long-term Assets  (calculated)57,497
+/- 589

Liabilities & Shareholders' Equity

Total Current Liabilities6,909
Long-term Liabilities17,253
Total Stockholder Equity52,228
Total Current Liabilities
Short Long Term Debt 337
Accounts payable 1,025
Other Current Liabilities 483
Total Current Liabilities  (as reported)6,909
Total Current Liabilities  (calculated)1,845
+/- 5,064
Long-term Liabilities
Long term Debt 9
Capital Lease Obligations Min Short Term Debt2,610
Long-term Liabilities  (as reported)17,253
Long-term Liabilities  (calculated)2,619
+/- 14,634
Total Stockholder Equity
Total Stockholder Equity (as reported)52,228
Total Stockholder Equity (calculated)0
+/- 52,228
Other
Capital Stock56,163
Common Stock Shares Outstanding 12,540
Net Invested Capital 52,574
Net Working Capital 11,395
Property Plant and Equipment Gross 4,023



6.3. Balance Sheets Structured

Currency in CHF. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
0
31,423
30,971
35,576
19,863
78,045
251,618
188,798
76,390
76,390188,798251,61878,04519,86335,57630,97131,4230
   > Total Current Assets 
0
615
166
351
263
46,853
54,970
22,583
18,304
18,30422,58354,97046,8532633511666150
       Cash And Cash Equivalents 
0
394
135
265
129
38,061
44,761
19,237
14,556
14,55619,23744,76138,0611292651353940
       Short-term Investments 
0
0
0
0
0
185
0
0
0
00018500000
       Net Receivables 
0
106
24
17
89
72
1,302
1,321
1,171
1,1711,3211,302728917241060
       Other Current Assets 
0
35
7
7
36
5,093
650
28
0
0286505,0933677350
   > Long-term Assets 
0
30,808
30,805
35,225
19,600
31,192
196,648
166,215
58,086
58,086166,215196,64831,19219,60035,22530,80530,8080
       Property Plant Equipment 
0
8
5
1
7
0
2,536
2,691
2,967
2,9672,6912,536071580
       Goodwill 
0
0
0
0
0
0
8,658
7,018
546
5467,0188,658000000
       Intangible Assets 
0
0
0
35,224
19,600
30,800
183,641
155,897
53,868
53,868155,897183,64130,80019,60035,224000
       Other Assets 
0
0
0
0
0
392
1,813
0
0
001,81339200000
> Total Liabilities 
0
9,187
10,026
14,293
5,565
11,002
70,088
43,381
24,162
24,16243,38170,08811,0025,56514,29310,0269,1870
   > Total Current Liabilities 
0
1,647
2,035
1,960
2,823
6,693
19,733
10,716
6,909
6,90910,71619,7336,6932,8231,9602,0351,6470
       Short-term Debt 
0
0
1,012
1,053
0
0
0
0
0
000001,0531,01200
       Short Long Term Debt 
0
0
1,012
328
962
0
95
372
337
3373729509623281,01200
       Accounts payable 
0
383
493
119
283
1,432
1,700
1,625
1,025
1,0251,6251,7001,4322831194933830
       Other Current Liabilities 
0
25
188
329
530
487
12,155
4,013
483
4834,01312,155487530329188250
   > Long-term Liabilities 
0
7,540
7,991
12,333
2,742
4,309
50,355
32,665
17,253
17,25332,66550,3554,3092,74212,3337,9917,5400
       Other Liabilities 
0
7,540
7,991
12,333
2,742
4,309
47,767
0
0
0047,7674,3092,74212,3337,9917,5400
> Total Stockholder Equity
0
22,236
20,945
21,283
14,298
67,043
181,530
145,417
52,228
52,228145,417181,53067,04314,29821,28320,94522,2360
   Common Stock
6,548
19,466
20,066
20,889
21,139
32,467
44,133
0
0
0044,13332,46721,13920,88920,06619,4666,548
   Retained Earnings -218,264-119,599-69,751-35,198-27,506-20,516-20,082-17,827-155
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
-6,446
135
185
209
214
1,228
2,626
5,273
0
05,2732,6261,228214209185135-6,446



6.4. Balance Sheets

Currency in CHF. All numbers in thousands.




6.5. Cash Flows

Currency in CHF. All numbers in thousands.




6.6. Income Statements

Currency in CHF. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CHF. All numbers in thousands.

Gross Profit (+$)
totalRevenue6,033
Cost of Revenue-1,736
Gross Profit4,2974,297
 
Operating Income (+$)
Gross Profit4,297
Operating Expense-25,811
Operating Income-19,778-21,514
 
Operating Expense (+$)
Research Development1,328
Selling General Administrative19,429
Selling And Marketing Expenses-
Operating Expense25,81120,757
 
Net Interest Income (+$)
Interest Income93
Interest Expense-330
Other Finance Cost-554
Net Interest Income-791
 
Pretax Income (+$)
Operating Income-19,778
Net Interest Income-791
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-111,68471,337
EBIT - interestExpense = -330
-98,181
-97,851
Interest Expense330
Earnings Before Interest and Taxes (EBIT)--111,354
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-111,684
Tax Provision--13,503
Net Income From Continuing Ops-98,181-98,181
Net Income-98,181
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-91,115791
 

Technical Analysis of Relief Therapeutics Holding SA
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Relief Therapeutics Holding SA. The general trend of Relief Therapeutics Holding SA is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Relief Therapeutics Holding SA's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Relief Therapeutics Holding SA.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 7.6 < 8.96 < 9.

The bearish price targets are: 6.25 > 4.75 > 3.58.

Tweet this
Relief Therapeutics Holding SA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Relief Therapeutics Holding SA. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Relief Therapeutics Holding SA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Relief Therapeutics Holding SA. The current macd is 0.62985052.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Relief Therapeutics Holding SA price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Relief Therapeutics Holding SA. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Relief Therapeutics Holding SA price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Relief Therapeutics Holding SA Daily Moving Average Convergence/Divergence (MACD) ChartRelief Therapeutics Holding SA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Relief Therapeutics Holding SA. The current adx is 31.47.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Relief Therapeutics Holding SA shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Relief Therapeutics Holding SA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Relief Therapeutics Holding SA. The current sar is 6.45.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Relief Therapeutics Holding SA Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Relief Therapeutics Holding SA. The current rsi is 61.63. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Relief Therapeutics Holding SA Daily Relative Strength Index (RSI) ChartRelief Therapeutics Holding SA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Relief Therapeutics Holding SA. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Relief Therapeutics Holding SA price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Relief Therapeutics Holding SA Daily Stochastic Oscillator ChartRelief Therapeutics Holding SA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Relief Therapeutics Holding SA. The current cci is 113.04.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Relief Therapeutics Holding SA Daily Commodity Channel Index (CCI) ChartRelief Therapeutics Holding SA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Relief Therapeutics Holding SA. The current cmo is 23.58.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Relief Therapeutics Holding SA Daily Chande Momentum Oscillator (CMO) ChartRelief Therapeutics Holding SA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Relief Therapeutics Holding SA. The current willr is -16.2962963.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Relief Therapeutics Holding SA Daily Williams %R ChartRelief Therapeutics Holding SA Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Relief Therapeutics Holding SA.

Relief Therapeutics Holding SA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Relief Therapeutics Holding SA. The current atr is 0.53829582.

Relief Therapeutics Holding SA Daily Average True Range (ATR) ChartRelief Therapeutics Holding SA Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Relief Therapeutics Holding SA. The current obv is -379,805.

Relief Therapeutics Holding SA Daily On-Balance Volume (OBV) ChartRelief Therapeutics Holding SA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Relief Therapeutics Holding SA. The current mfi is 43.22.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Relief Therapeutics Holding SA Daily Money Flow Index (MFI) ChartRelief Therapeutics Holding SA Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Relief Therapeutics Holding SA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-06-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Relief Therapeutics Holding SA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Relief Therapeutics Holding SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.630
Ma 20Greater thanMa 506.733
Ma 50Greater thanMa 1004.670
Ma 100Greater thanMa 2002.979
OpenGreater thanClose7.570
Total5/5 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Relief Therapeutics Holding SA with someone you think should read this too:
  • Are you bullish or bearish on Relief Therapeutics Holding SA? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Relief Therapeutics Holding SA? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Relief Therapeutics Holding SA

I send you an email if I find something interesting about Relief Therapeutics Holding SA.


Comments

How you think about this?

Leave a comment

Stay informed about Relief Therapeutics Holding SA.

Receive notifications about Relief Therapeutics Holding SA in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.